Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
2.340
+0.030 (1.30%)
Nov 22, 2024, 4:00 PM EST - Market closed

Oramed Pharmaceuticals Revenue

In the year 2023, Oramed Pharmaceuticals had annual revenue of $1.34M, down -50.43%.

Revenue (ttm)
$1.34M
Revenue Growth
-50.43%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
94.33M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.34M-1.36M-50.43%
Dec 31, 20222.70M-9.00K-0.33%
Dec 31, 20212.71M9.00K0.33%
Aug 31, 20212.70M-9.00K-0.33%
Dec 31, 20202.71M2.00K0.07%
Aug 31, 2020 Pro Pro Pro
Aug 31, 2019 Pro Pro Pro
Aug 31, 2018 Pro Pro Pro
Aug 31, 2017 Pro Pro Pro
Aug 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
PetMed Express 259.34M
So-Young International 212.14M
Assertio Holdings 125.76M
Harvard Bioscience 97.73M
EDAP TMS 70.72M
908 Devices 55.16M
Assembly Biosciences 28.33M
Veru Inc. 14.09M
Revenue Rankings